# Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery

> **NCT07740655** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jeju National University School of Medicine** · enrollment: 138 (estimated)

## Conditions studied

- Emergence Agitation
- General Anesthesia
- Nasal Surgical Procedures

## Interventions

- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT07740655
- **Lead sponsor:** Jeju National University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-24
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740655, "Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07740655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*